The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students

Annual influenza vaccination of health care students and workers helps protect themselves and patients from influenza, which has a high disease burden during seasonal peaks in Australia. Health care students are an important cohort whose early attitudes and habits towards influenza vaccination may influence future behaviours. We explored the knowledge, attitudes, and behaviours towards influenza vaccination of health care students in two universities from 2018 to 2020 using convergent mixed methodology. We also assessed the impact of two external events – the introduction of mandatory influenza vaccination for select students in 2019, and the COVID-19 pandemic in 2020. We found a significant increase in self-reported vaccination uptake between 2018 (73.5%) and 2020 (89.6%), with the mandate and COVID-19 pandemic being likely drivers of increased uptake. Vaccine mandates are effective but must be supported by easy accessibility, adequately addressing concerns around effectiveness and safety, and promotion of voluntary acceptance and trust

Starting healthy habits early: Influenza vaccination among student health care workers

Background: A 2014 study demonstrated low rates of influenza vaccination among health care worker [HCW] students at the University of Notre Dame [UND], 56% (95% CI 52-60%) overall weighted average, 53%, 57% and 61% for nursing, physiotherapy and medical students, respectively. Since then, annual influenza vaccination and/or documentation of influenza vaccination status has become mandatory for these students. On- campus influenza vaccination became available in 2018. Method: HCW students at UND were invited to participate in online surveys of influenza vaccination uptake in 2018 and 2019. Semi-structured interviews were conducted to collect qualitative data on enablers and barriers to vaccination. Results: A total of 422 students responded to the survey (199 in 2018 and 223 in 2019). The overall weighted vaccination rate of respondents was 91% (95% CI 88-93%) (79%, 90% and 95% for nursing, physiotherapy and medical students, respectively), a significant increase from 2014. Vaccination uptake in medical students increased from 83% (95% CI 76-90%) in 2018 to 99% (95% CI 96-100%) (P < 0.001) after reporting of vaccination status was mandated in 2019. Qualitative data regarding enablers, barriers, knowledge and understanding of influenza and the influenza vaccine, among HCW students and will be presented at the conference. Conclusion: Influenza vaccination uptake among UND HCW students increased significantly following the introduction of mandatory vaccination/reporting of vaccination, and is higher than the 50% observed in HCWs employed by the WA Department of Health. It is hoped that this behaviour will continue after graduation upon entering workplaces where vaccination is not mandated

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

Summary: Introduction: Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease, with significant potential for positive impact on public health and healthcare savings. New clinical practice recommendations are presented in an abridged guidance to assist practitioners in enhancing the care of all patients with FH. Main recommendations: Core recommendations are made on the detection, diagnosis, assessment and management of adults, children and adolescents with FH. There is a key role for general practitioners (GPs) working in collaboration with specialists with expertise in lipidology. Advice is given on genetic and cholesterol testing and risk notification of biological relatives undergoing cascade testing for FH; all healthcare professionals should develop skills in genomic medicine. Management is under-pinned by the precepts of risk stratification, adherence to healthy lifestyles, treatment of non-cholesterol risk factors, and appropriate use of low-density lipoprotein (LDL)-cholesterol lowering therapies, including statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Recommendations on service design are provided in the full guidance. Potential impact on care of FH: These recommendations need to be utilised using judicious clinical judgement and shared decision making with patients and families. Models of care need to be adapted to both local and regional needs and resources. In Australia new government funded schemes for genetic testing and use of PCSK9 inhibitors, as well as the National Health Genomics Policy Framework, will enable adoption of these recommendations. A broad implementation science strategy is, however, required to ensure that the guidance translates into benefit for all families with FH